Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nephrocare Health Services (Nephroplus) has disclosed that company officials will attend an investor conference hosted by Bank of America on June 4, 2026 at 8:00 AM IST onwards in Hyderabad. The meeting is part of the BoFA Healthcare Tour and includes both group and one-on-one meetings with analysts and institutional investors. The company has clarified that discussions will be based solely on publicly available information and no unpublished price sensitive information (UPSI) will be shared. This is a routine regulatory compliance filing under SEBI Listing Regulations.
This disclosure signals active investor relations engagement, which is typically viewed positively as it indicates management transparency and accessibility to institutional investors. However, since no material information will be shared, the filing itself has no immediate impact on the stock.